StoxNeochem Bio Solutions Limited
NSE: NEOCHEM · Unclassified
Ask the data
Instant answers about Neochem Bio Solutions Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY26 | |
|---|---|
| Revenue | 110.7 |
| EBITDA | 19.9 |
| Operating margin | 17.9% |
| Interest | 3.5 |
| Depreciation | 1.2 |
| Profit before tax | 17.2 |
| Tax | 4.8 |
| Net profit | 12.3 |
| EPS ₹ | 8.71 |
| Operating cash flow | -8.6 |
| Capex | 0.0 |
| Dividend paid | 0.0 |
| Total assets | 117.1 |
| Equity | 78.8 |
Half-yearly performance
last 3 half years · ₹ crore| H1 FY26* | H2 FY26 | H1 FY27 | |
|---|---|---|---|
| Revenue | 45.8 | 64.9 | 68.9 |
| Operating profit | 8.6 | 11.3 | 12.0 |
| Operating margin | 18.7% | 17.4% | 17.5% |
| Other income | 1.4 | 1.4 | 0.4 |
| Interest | 2.0 | 1.5 | 1.3 |
| Depreciation | 0.6 | 0.6 | 0.7 |
| Profit before tax | 7.3 | 9.8 | 10.5 |
| Tax | 1.8 | 3.0 | 2.6 |
| Net profit | 5.5 | 6.9 | 7.8 |
| EPS ₹ | 3.74 | 4.97 | 4.58 |
| Revenue YoY | — | — | 50.4% |
| Profit YoY | — | — | 43.2% |
Returns & margins
trailing-twelve-month, per half year| H2 FY26 | H1 FY27 | |
|---|---|---|
| ROE | 15.7% | 17.0% |
| ROCE | 21.4% | 19.3% |
| Net margin | 11.1% | 11.0% |
| EBITDA margin | 17.9% | 17.4% |
| Debt / equity | 0.23 | 0.38 |
| Interest coverage | 5.89 | 8.28 |
| Asset turnover | 0.95 | 0.90 |
Balance sheet
equity vs borrowings over time · ₹ crore| MAR '26 | SEP '26 | |
|---|---|---|
| Share capital | 17.1 | 17.1 |
| Other equity / reserves | 61.7 | 69.6 |
| Total equity | 78.8 | 86.7 |
| Borrowings | 17.8 | 33.1 |
| Current liabilities | 35.9 | 55.0 |
| Non-current liabilities | 2.4 | 7.1 |
| Total assets | 117.1 | 148.9 |
| Property, plant & equipment | 19.9 | 30.9 |
| Investments | 6.2 | 5.1 |
| Inventories | 29.2 | 40.4 |
| Receivables | 48.7 | 48.1 |
| Cash & equivalents | 0.2 | 0.2 |
Cash flow
annual · ₹ crore · line = free cash flow| FY26 | |
|---|---|
| Cash from operations | -8.6 |
| Cash from investing | 6.0 |
| Cash from financing | 65.5 |
| Capex | 0.0 |
| Free cash flow | -8.6 |
| Dividends paid | 0.0 |
Where the assets sit
Sep '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Neochem Bio Solutions Limited | 182 | 106.25 | 12.4 | 2.10 | 17.0% |
StoxGud checklist: Bullish setup · 9/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Neochem Bio Solutions Limited?
Neochem Bio Solutions Limited (NEOCHEM) closed at ₹106.25 on NSE on 06 Nov 2026.
What is the market cap of Neochem Bio Solutions Limited?
₹182 crore at the latest close.
What is the P/E ratio of Neochem Bio Solutions Limited?
12.4, on trailing-twelve-month earnings from its filings.
How fast is Neochem Bio Solutions Limited growing?
Neochem Bio Solutions Limited: Latest-half-year revenue is up 50.4% year on year, profit up 43.2%.
How profitable is Neochem Bio Solutions Limited?
On a trailing-twelve-month basis return on equity is 17.0%, return on capital employed 19.3%, operating margin 17.4%, net margin 11.0%.
How much debt does Neochem Bio Solutions Limited have?
Neochem Bio Solutions Limited is lightly geared: debt to equity is 0.38 with borrowings of ₹33 cr against cash of ₹0 cr (balance sheet of 2026-09-30). Operating profit covers interest 8.3 times.
Financials parsed from Neochem Bio Solutions Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Half-yearly from H1 FY26, annual from FY26, balance sheet from Mar '26. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.